115 related articles for article (PubMed ID: 10833512)
1. A 3'-5' exonuclease in human leukemia cells: implications for resistance to 1-beta -D-arabinofuranosylcytosine and 9-beta -D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate.
Skalski V; Brown KR; Choi BY; Lin ZY; Chen S
J Biol Chem; 2000 Aug; 275(33):25814-9. PubMed ID: 10833512
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 3'-->5'-exonuclease that removes cytosine arabinoside monophosphate from 3' termini of DNA.
Perrino FW; Miller H; Ealey KA
J Biol Chem; 1994 Jun; 269(23):16357-63. PubMed ID: 8206943
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5-monophosphate (fludarabine, NSC 312887) in a human tumor cloning system.
Lathan B; Diehl V; Clark GM; von Hoff DD
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1891-5. PubMed ID: 2464493
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.
Danhauser L; Plunkett W; Liliemark J; Gandhi V; Iacoboni S; Keating M
Leukemia; 1987 Sep; 1(9):638-43. PubMed ID: 3478543
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type I DNA polymerase. Kinetic properties of the associated 3'-5' exonuclease activity and its role in araAMP incorporation.
Derse D; Cheng YC
J Biol Chem; 1981 Aug; 256(16):8525-30. PubMed ID: 6167579
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells.
Allaudeen HS; Kozarich JW; Sartorelli AC
Nucleic Acids Res; 1982 Feb; 10(4):1379-87. PubMed ID: 6175955
[TBL] [Abstract][Full Text] [Related]
7. Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity.
Huang P; Chubb S; Plunkett W
J Biol Chem; 1990 Sep; 265(27):16617-25. PubMed ID: 1697861
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
Avramis VI; Plunkett W
Cancer Drug Deliv; 1983; 1(1):1-10. PubMed ID: 6085754
[TBL] [Abstract][Full Text] [Related]
9. Altered sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate of DNA polymerase alpha from leukemic blasts of acute lymphoblastic leukemia.
TAnaka M; Yoshida S
Cancer Res; 1982 Feb; 42(2):649-53. PubMed ID: 6948608
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA polymerase-alpha by ara-CMP in the presence of a regulatory protein extracted from human promyelocytic leukemic cells (HL-60).
Leclerc JM; Grisé-Miron L; Labonté L
Semin Oncol; 1987 Jun; 14(2 Suppl 1):226-30. PubMed ID: 3473678
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human cytomegalovirus-induced DNA polymerase and the associated 3'-to-5', exonuclease.
Nishiyama Y; Maeno K; Yoshida S
Virology; 1983 Jan; 124(2):221-31. PubMed ID: 6186074
[TBL] [Abstract][Full Text] [Related]
12. 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma.
Danhauser L; Plunkett W; Keating M; Cabanillas F
Cancer Chemother Pharmacol; 1986; 18(2):145-52. PubMed ID: 2431803
[TBL] [Abstract][Full Text] [Related]
13. 1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells.
Myers-Robfogel MW; Spataro AC
Cancer Res; 1980 Jun; 40(6):1940-3. PubMed ID: 7371029
[TBL] [Abstract][Full Text] [Related]
14. In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Ichikawa A; Furukawa Y; Bai L; Kon K
Leukemia; 2000 Mar; 14(3):379-88. PubMed ID: 10720130
[TBL] [Abstract][Full Text] [Related]
15. Exonucleases and the incorporation of aranucleotides into DNA.
Perrino FW; Mazur DJ; Ward H; Harvey S
Cell Biochem Biophys; 1999; 30(3):331-52. PubMed ID: 10403055
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative potency of 9-beta-D-arabinofuranosyl-2-fluoroadenine phospholipid adducts.
Brachwitz H; Bergmann J; Thomas Y; Wollny T; Langen P
Bioorg Med Chem; 1999 Jun; 7(6):1195-200. PubMed ID: 10428391
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
Nagahata T; Shibasaki C; Ishii T; Uchida T; Arakawa M; Kusama K; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Ueda T; Kamiya K; Urasaki Y; Wataya S; Kawai Y; Tsutani H; Sugiyama M; Nakamura T
Cancer Res; 1994 Jan; 54(1):109-13. PubMed ID: 8261429
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.
Avramis VI; Champagne J; Sato J; Krailo M; Ettinger LJ; Poplack DG; Finkelstein J; Reaman G; Hammond GD; Holcenberg JS
Cancer Res; 1990 Nov; 50(22):7226-31. PubMed ID: 1699658
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
Gandhi V; Plunkett W
Cancer Chemother Pharmacol; 1992; 31(1):11-7. PubMed ID: 1458554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
